课题基金 / 基金详情

Modulation of G protein-coupled receptor trafficking and activity by receptor-interacting proteins

Modulation of G protein-coupled receptor trafficking and activity by receptor-interacting proteins
受体相互作用蛋白对 G 蛋白偶联受体运输和活性的调节
批准号:
RGPIN-2014-06358
负责人:
Sarret, Philippe
金额:
$3.42万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-01-01 至 2017-12-31

项目摘要

项目成果

Sarret, Philippe的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
G protein-coupled receptors (GPCRs) belong to a superfamily of cell-surface receptors that regulate a variety of cellular functions by responding to diverse extracellular stimuli. Plasma membrane expression of these GPCRs is a dynamic process balancing anterograde and retrograde trafficking. In this context, export of neo-synthesized GPCRs from intracellular compartments to the cell surface represents a crucial checkpoint in controlling the level of functional receptors available at the plasma membrane and the magnitude of the cellular response elicited by a ligand. Although cell-surface export of GPCRs is commonly considered to implicate the constitutive unregulated secretory pathway, there is now growing evidence indicating that the post-Golgi trafficking of these transmembrane receptors to the cell surface is dynamically regulated by molecular chaperones/accessory escort proteins and may also rely on the non-canonical regulated secretory pathway via their packaging into large dense-core vesicles (LDCVs). However, in contrast to the extensive efforts dedicated to understanding the events involved in the endocytic and recycling pathways, the molecular mechanisms underlying GPCR transport to the plasma membrane remain poorly defined. We previously demonstrated that the neurotensin (NT) receptor subtype 2 (NTS2), belonging to the class A of GPCRs is mainly associated with intracellular organelles and that sustained NT exposure promotes cell surface recruitment of NTS2. In addition, using the yeast two-hybrid system to screen for proteins that interact with the third intracellular loop of NTS2, we recently identified the secretogranin III (SgIII) as a new NTS2-interacting protein. Classified as a member of the granin protein family, SgIII ensures the sorting of bioactive peptides to secretory granules. Our FIRST OBJECTIVE is therefore to characterize the SgIII-NTS2 molecular interaction by using in vitro GST pull-down assays as well as co-immunoprecipitation and FRET studies in a cellular context using tagged fusion proteins. Additionally, we will use a site-directed mutagenesis method to further refine the molecular determinants of NTS2 involved in the interaction with SgIII. The SECOND OBJECTIVE will help to determine whether SgIII regulates the cell surface expression of NTS2 by promoting its packaging into LDCVs and modulates NTS2 physiological function. For this purpose, we will investigate the effects of the down-regulation of SgIII by the use of 27-mer Dicer-substrate siRNA (DsiRNA) on the number of bioavailable NTS2 receptors at the cell surface and on its coupling to the ERK1/2 signaling pathway in response to agonist stimulation. Finally, we will determine whether the sorting of NTS2 through the regulated secretory pathway is important for spinal analgesia. ER/post-Golgi export is a rate-limiting step for cell surface transport of nascent GPCRs. Recent progress suggest that the sorting of GPCRs into distinct secretory pathways is determined not only by the intrinsic properties of these proteins but also by the extrinsic molecular chaperones/accessory proteins that interact with these receptors. OUR LONG-TERM GOAL is thus to better understand how this ER-Golgi-cell surface transport of GPCRs is regulated by identifying and characterizing new molecular escort proteins involved in the sorting of GPCRs, notably through the regulated secretory pathway. To gain insight into mechanisms that regulate the sorting of these GPCRs via the non-canonical pathway, we propose to perform immunoprecipitations with specific antibodies raised against different GPCRs associated with LDCV-enriched fractions combined with a functional mass spectrometry (MS)-based proteomic approach for the identification of new GPCR associated escort proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of G protein-coupled receptor trafficking and activity by receptor-interacting proteins
  • 批准号:
    RGPIN-2014-06358
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2021
  • 负责人:
    Sarret, Philippe
  • 依托单位:
Modulation of G protein-coupled receptor trafficking and activity by receptor-interacting proteins
  • 批准号:
    RGPIN-2014-06358
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2020
  • 负责人:
    Sarret, Philippe
  • 依托单位:
Modulation of G protein-coupled receptor trafficking and activity by receptor-interacting proteins
  • 批准号:
    RGPIN-2014-06358
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2017
  • 负责人:
    Sarret, Philippe
  • 依托单位:
Identification of G Protein-coupled receptor associated sorting proteins through a functional mass spectrometry (MS)-based proteomic approach.
  • 批准号:
    479273-2015
  • 项目类别:
    Engage Grants Program
  • 资助金额:
    $1.82万
  • 财政年份:
    2015
  • 负责人:
    Sarret, Philippe
  • 依托单位:
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: